I-Mab to Report Financial Results for Full Year 2019 and Provide Corporate Update on March 31, 2020
I-MAB - American Depositary Shares (IMAB)
Company Research
Source: GlobeNewswire
SHANGHAI, China and ROCKVILLE, MD., March 11, 2020 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders, today announced that it will release its financial results for the twelve month period ended December 31, 2019 before the market opens on Tuesday, March 31, 2020 and host a conference call to discuss the results at 8:00 a.m. ET. On the call, I-Mab’s senior management team will also provide an update on the Company’s business and upcoming milestones. The live webcast and a replay may be accessed by visiting the Company’s website at http://ir.i-mabbiopharma.com. Alternatively, please call +1 8665194004 (U.S.), +65 67135090 (International), 4006208038 (Mainland China), or 800906601 (Hong Kong) to listen to the live conference call
Show less
Read more
Impact Snapshot
Event Time:
IMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMAB alerts
High impacting I-MAB - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMAB
News
- I-Mab to Participate at the Piper Sandler Healthcare ConferencePR Newswire
- I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.MarketBeat
- I-Mab Reports Third Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
- I-Mab Reports Third Quarter 2024 ResultsPR Newswire
- I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive OfficerPR Newswire
IMAB
Earnings
- 11/14/24 - Miss
IMAB
Sec Filings
- 11/14/24 - Form 6-K
- 11/6/24 - Form 6-K
- 11/5/24 - Form 6-K
- IMAB's page on the SEC website